Legacy Health Strategies
Legacy Health Strategies is dedicated to transforming pharmaceutical R&D into an equity-centered, patient engagement partnership. They focus on advancing health equity, accelerating drug development, and delivering life-changing medicines through innovative, inclusive engagement strategies. Their mission is to bridge the gap between what patients want and what healthcare industry needs, fostering trust, transparency, and collaboration in clinical research.
Industries
Nr. of Employees
small (1-50)
Legacy Health Strategies
San Diego, California, United States
Products
Participant data-return implementation roadmap
A documented process map and practical guidance for implementing participant data return, covering consent language, participant registration, timing, data transformation to patient-friendly formats, and secure delivery options.
Trial-ready bi-directional engagement model (simulation)
An immersive simulation that models participant experiences and communication flows to demonstrate retention levers and participant support mechanisms for planning near real-time communications.
L-Trial Ready
Legacy's platform connects social health communities and social media sites with information about clinical trials, helping to ensure the right qualified patients are recruited faster, educated, and retained through trial completion.
Trial Ready Communities (L-TRC)
Legacy's platform connects social health communities and social media sites with information about clinical trials, helping to ensure the right qualified patients are recruited faster, educated, and retained through trial completion.
L-Trial Ready Communities
An innovative solution based on engaging a wider community of people living with a condition who may not otherwise know about clinical trials.
Trial Ready Community
Service focused on preparing communities for clinical trial participation and awareness.
Participant data-return implementation roadmap
A documented process map and practical guidance for implementing participant data return, covering consent language, participant registration, timing, data transformation to patient-friendly formats, and secure delivery options.
Trial-ready bi-directional engagement model (simulation)
An immersive simulation that models participant experiences and communication flows to demonstrate retention levers and participant support mechanisms for planning near real-time communications.
L-Trial Ready
Legacy's platform connects social health communities and social media sites with information about clinical trials, helping to ensure the right qualified patients are recruited faster, educated, and retained through trial completion.
Trial Ready Communities (L-TRC)
Legacy's platform connects social health communities and social media sites with information about clinical trials, helping to ensure the right qualified patients are recruited faster, educated, and retained through trial completion.
L-Trial Ready Communities
An innovative solution based on engaging a wider community of people living with a condition who may not otherwise know about clinical trials.
Trial Ready Community
Service focused on preparing communities for clinical trial participation and awareness.
Services
Strategic consulting to design and implement equity-centered patient engagement programs across clinical development stages.
Design and integration of secure two-way communication systems and automated workflows, including vendor selection and platform integration to support pre-trial, on-trial, and post-trial engagement.
Program design and vendor coordination for returning individual and aggregate trial data to participants, including consent workflows, plain-language summaries, and secure delivery mechanisms.
Design and operational execution of community-focused screening events and studies to identify unmet health needs and engage underrepresented populations.
Educational webinars, workshops, and immersive simulations to train sponsor leadership, clinical operations, and patient engagement teams on patient-centered communications and engagement practices.
Strategic consulting to design and implement equity-centered patient engagement programs across clinical development stages.
Design and integration of secure two-way communication systems and automated workflows, including vendor selection and platform integration to support pre-trial, on-trial, and post-trial engagement.
Program design and vendor coordination for returning individual and aggregate trial data to participants, including consent workflows, plain-language summaries, and secure delivery mechanisms.
Design and operational execution of community-focused screening events and studies to identify unmet health needs and engage underrepresented populations.
Educational webinars, workshops, and immersive simulations to train sponsor leadership, clinical operations, and patient engagement teams on patient-centered communications and engagement practices.
Expertise Areas
- Patient engagement strategy
- Clinical trial recruitment and retention
- Digital participant communications
- Participant data return and governance
Key Technologies
- Two-way messaging systems for participants
- Secure participant data delivery platforms
- Plain-language summary generation
- Design-thinking and qualitative methods
News & Updates
Jessica Scott, MD, JD, CEO of Legacy Health Strategies, will join an upcoming webinar panel hosted by the MRCT to discuss long-term follow-up in cell and gene therapies.
Jessica Scott, MD, JD, joins a roundtable to discuss the future of ethics and patient-centricity in pharmaceutical research.
Jessica Scott, MD, JD, and CEO of Legacy, participated in the World Orphan Drug Congress to discuss data return in rare disease trials.
Jessica Scott, MD, JD, and CEO of Legacy, unveiled a new immersive experience to reimagine clinical trial communication at the Chief Patient Officer Summit.
Legacy published an article exploring the benefits and significance of merging patient engagement with diversity, equity, and inclusion in medical product development.
An article highlighting the personal commitment and passion of Legacy’s team members, inspired by their own healthcare journeys.
Jessica Scott, MD, JD, CEO of Legacy Health Strategies, will join an upcoming webinar panel hosted by the MRCT to discuss long-term follow-up in cell and gene therapies.
Jessica Scott, MD, JD, joins a roundtable to discuss the future of ethics and patient-centricity in pharmaceutical research.
Jessica Scott, MD, JD, and CEO of Legacy, participated in the World Orphan Drug Congress to discuss data return in rare disease trials.
Jessica Scott, MD, JD, and CEO of Legacy, unveiled a new immersive experience to reimagine clinical trial communication at the Chief Patient Officer Summit.
Legacy published an article exploring the benefits and significance of merging patient engagement with diversity, equity, and inclusion in medical product development.
An article highlighting the personal commitment and passion of Legacy’s team members, inspired by their own healthcare journeys.